✦ LIBER ✦

Vascular changes in hemodialysis patients in response to recombinant human erythropoietin

✍ Scribed by London, Gérard M; Zins, Brigitte; Pannier, Bruno; Naret, Catherine; Berthelot, Jean-Michel; Jacquot, Christian; Safar, Michel; Drueke, Tilman B

Book ID: 109881373
Publisher: Nature Publishing Group
Year: 1989
Tongue: English
Weight: 526 KB
Volume: 36
Category: Article
ISSN: 0085-2538
DOI: 10.1038/ki.1989.274

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hemoglobin cycling in hemodialysis patie

Hemoglobin cycling in hemodialysis patients treated with recombinant human erythropoietin

✍ Fishbane, Steven; Berns, Jeffrey S. 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 126 KB

Effect of chronic human recombinant eryt

Effect of chronic human recombinant erythropoietin therapy on antibody responses to immunization in chronic hemodialysis patients

✍ Birmingham, Daniel J; Shen, Xiao-Ping; Hartman, Judith A; Dillon, John J; Hebert 📂 Article 📅 1996 🏛 Nature Publishing Group 🌐 English ⚖ 519 KB

Effect of recombinant human erythropoiet

Effect of recombinant human erythropoietin on insulin resistance in hemodialysis patients

✍ Essam KHEDR; Magdy EL-SHARKAWY; Saed ABDULWAHAB; Essam Nor ELDIN; Medhat ALI; Ab 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

Effect of recombinant human erythropoiet

Effect of recombinant human erythropoietin on plasma von Willebrand factor in chronic hemodialysis patients

✍ Jolan Harsfalvi; Zoltan Boda; Janos Mikita; Istvan Karpati; György Kakuk; Kalman 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 474 KB 👁 2 views

Recombinant human erythropoietin enhance

Recombinant human erythropoietin enhances superoxide production by FMLP-stimulated polymorphonuclear leukocytes in hemodialysis patients

✍ Chen, Hung-Chun; Tsai, Jer-Chia; Tsai, Juei-Hsiung; Lai, Yung-Hsiung 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 512 KB

Response predicting factors to recombina

Response predicting factors to recombinant human erythropoietin in cancer patients undergoing platinum-based chemotherapy

✍ Manolo González-Barón; Amdio Ordóñez; Rosa Franquesa; Manuel Constenla; Joaquin 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

## Background: The response to epoetin-alpha treatment is hard to predict in cancer patients receiving chemotherapy. ## Methods: One hundred and seventeen patients were enrolled in this observational study. they had a hemoglobin (hb) level less than or equal to 10.5 g/dl, were receiving platinum